Agios Pharmaceuticals, Inc. AGIO · SEC Filings

website

540

Agios Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to the research and advancement of...

Price31.38

Market Cap1.87 B

Float58.25 M

CountryUS

SectorHealthcare

ExchangeNASDAQ

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

Financials

TYPE

HEADLINE

FILED AT

News

TYPE

HEADLINE

FILED AT

8-K

Agios Reports Third Quarter 2026 Financial Results and Provides Business Update

Nov 5, 2026

8-K

Agios Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Updates

Jul 30, 2026

8-K

Agios Pharmaceuticals, Inc. Announces Results of 2026 Annual Meeting of Stockholders

Jun 18, 2026

8-K

Agios Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Updates

Apr 29, 2026

8-K

Agios Reports Fourth Quarter and Full Year 2025 Financial Results

Feb 12, 2026

8-K

Agios Pharmaceuticals Announces 2026 Strategic Priorities and Key Milestones for Rare Disease Growth

Jan 12, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B5